Q22 helps MedTech, Pharma and Life Sciences companies enter markets, build partnerships and turn commercial ambition into traction.
I support founders, investors and international growth companies with European market entry, interim business development, strategic partnerships, licensing, funding preparation and hands on commercial execution.
Q22 helpt MedTech, Pharma en Life Sciences bedrijven om markten te betreden, partnerships op te bouwen en commerciële ambitie om te zetten in tractie.
Ik ondersteun founders, investeerders en internationale groeibedrijven met Europese markttoegang, interim business development, strategische partnerships, licensing, fundingvoorbereiding en praktische commerciële uitvoering.
Built on experience across leading healthcare, pharma and life sciences organisations
Gebouwd op ervaring bij toonaangevende organisaties in healthcare, pharma en life sciences
Enter Europe with the right market focus, partner strategy, operational setup and commercial approach.
Europa betreden met de juiste marktfocus, partnerstrategie, operationele inrichting en commerciële aanpak.
Build pipeline, open strategic accounts, approach partners and create commercial momentum.
Pipeline bouwen, strategische accounts openen, partners benaderen en commerciële voortgang creëren.
Find, approach and structure licensing, distribution, CDMO and commercial partnerships.
Het vinden, benaderen en structureren van licensing, distributie, CDMO en commerciële partnerships.
Move from concept, IP and funding preparation to commercial strategy and market execution.
Van concept, IP en fundingvoorbereiding naar commerciële strategie en marktuitvoering.
Turn complex technology into a clear value story for customers, partners and investors.
Complexe technologie vertalen naar een duidelijke waardepropositie voor investeerders en partners.
Access trusted partners for legal, regulatory, quality, logistics, repair, returns and administration.
Toegang tot betrouwbare partners voor legal, regulatory, quality, logistiek, repair en administratie.
Many companies have strong technology, but struggle to turn it into customers, partners, funding or market access.
Veel bedrijven hebben sterke technologie, maar moeite om dit te vertalen naar klanten, partners, funding of markttoegang.
The challenge is often not the product itself. The challenge is focus, positioning, execution and access to the right people.
Het probleem zit vaak niet in het product zelf. Het probleem zit in focus, positionering, uitvoering en toegang tot de juiste mensen.
Q22 helps bridge that gap. I combine senior commercial experience with hands-on execution, so plans move into real conversations, partnerships and market traction.
Q22 helpt om die brug te slaan. Ik combineer senior commerciële ervaring met een hands-on aanpak, zodat plannen worden omgezet in gesprekken, partnerships en markttractie.
Strategy + Execution
Q22 is relevant for:
Q22 is relevant voor:
Q22 supports companies where commercial strategy needs to become real progress. The work is practical, senior and focused on movement, finding the right market, the right partners and the right next steps. Q22 ondersteunt bedrijven op het punt waar commerciële strategie moet worden omgezet in echte voortgang. Het werk is praktisch, senior en gericht op beweging, de juiste markt en de juiste partners.
For international MedTech, Pharma and Life Sciences companies that want to enter or expand in Europe.
Voor internationale MedTech, Pharma en Life Sciences bedrijven die de Europese markt willen betreden of hierin willen uitbreiden.
For companies that need senior commercial execution without hiring a full-time business development team immediately.
Voor bedrijven die senior commerciële executie nodig hebben zonder direct een fulltime team aan te nemen.
Finding, approaching and structuring licensing, distribution, CDMO and commercial partnerships.
Het vinden, benaderen en structureren van licensing, distributie, CDMO en commerciële partnerships.
Find the right partnersFrom concept, IP and funding preparation to commercial strategy and market execution.
Van concept, IP en fundingvoorbereiding naar commerciële strategie en marktuitvoering.
Prepare your ventureTurning complex technology into a clear value story for customers, partners and investors.
Complexe technologie vertalen naar een duidelijke propositie voor klanten, partners en investeerders.
Sharpen your propositionAccess trusted partners for legal, regulatory, quality, logistics, repair, returns and administration.
Toegang tot betrouwbare partners voor legal, regulatory, quality, logistiek en administratie.
Build your European setup€7M+
Funding Raised
2
Concepts to Patient
GMP
Pharma Lab Built
20+ Yrs
Experience
Q22 is built on more than 20 years of commercial and strategic experience across healthcare, pharma, MedTech, medical nutrition, ingredient technologies and Life Sciences. Experience ranges from funding processes and building GMP certified labs to market access and home-based care coordination.
Defining what needs to happen commercially, strategically or operationally to move from ambition to traction.
Mapping target countries, partners, stakeholders and operational requirements for a realistic route to market.
Creating the necessary tools, pitch narratives, partner profiles and market entry roadmaps to engage the market.
Q22 is not only advisory. I actively support outreach, introductions, meetings, and deal progression.
Q22 was founded by Ivo Schefman, a senior commercial operator with more than 20 years of experience across healthcare, pharma, MedTech, medical nutrition, ingredient technologies and Life Sciences.
Ivo has worked across sales, market access, business development, licensing, funding, healthcare at home and venture building. His strength lies in connecting strategy with practical execution, bringing the right people together and moving opportunities forward.
Get in touchAre you building, scaling or entering Europe in MedTech, Pharma, Life Sciences or healthcare? Q22 helps you move from ambition to execution.